- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22.05. | NICE changes stance on Genmab's cervical cancer drug | ||
| 22.05. | Biogen, Denali pull Parkinson's drug after failed trial | ||
| 21.05. | Europe is facing a surge in STIs, says ECDC | ||
| 21.05. | Lilly's 'triple G' retatrutide aces crucial obesity trial | ||
| 21.05. | Infex chases after Insmed with bronchiectasis trial win | ||
| 21.05. | Bayer gets swift review for Kerendia in type 1 diabetes | ||
| 21.05. | Novo Nordisk fight with KBP Bio will go to arbitration | ||
| 20.05. | Remepy's hybrid Parkinson's therapy poised for phase 3 | ||
| 20.05. | Pfizer takes 25-valent Prevnar follow-up into phase 3 | ||
| 20.05. | Doctors dismayed by report of NHS AI proposal | ||
| 20.05. | As Ebola deaths climb, search begins for vaccine | ||
| 20.05. | GHO, CBC merge to create largest healthcare investment firm | ||
| 20.05. | Tuneable peptide biotech Parabilis files IPO | ||
| 19.05. | OpenBind unveils its first AI model for drug discovery | ||
| 19.05. | Jury finds Takeda liable for $885m in pay-for-delay lawsuit | ||
| 19.05. | European study shows inequality in access to new medicines | ||
| 19.05. | Sanofi says drug for rare disease AATD tops standard care | ||
| 19.05. | SCOTUS won't hear pharma's IRA complaints | ||
| 18.05. | MSD's Sac-TMT delivers in first phase 3 readout | ||
| 18.05. | Novartis reveals more data behind Pluvicto expansion bid | ||
| 18.05. | WHO says Ebola outbreak in Congo is a "public emergency" | ||
| 18.05. | AZ gets first okay for new hypertension drug baxdrostat | ||
| 18.05. | Another LAG-3 setback as Regeneron drug fails phase 3 trial | ||
| 18.05. | After refusing to resign, CDER head Høeg is fired | ||
| 15.05. | Lilly UK recruits ex-England cricketer as obesity champion |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.